Web10 jul. 2003 · Main. Cytarabine (cytosine arabinoside) is a powerful antimetabolite used in the treatment of acute myeloid leukaemia (AML). Corneal toxicity from high-dose intravenous cytarabine therapy has been ... WebHowever, an increased risk of neurotoxicity has been associated with high dose cytarabine with creatinine clearance less than 60 mL/min. Melphalan : In patients with renal impairment, haematological recovery was not delayed, however non-haematological toxicity and transplant-related mortality was found to be higher.
1674-R-DHAOx (rituximab dexamethasone cytarabine …
WebHigh-dose cytarabine is up to 30 times the standard dose of this drug. Although more effective, the higher dose is more toxic. In this study, an intermediate dose was equally … Web26 apr. 2024 · Patients treated with high doses of cytarabine should be observed for neuropathy since dose adjustments may be needed to avoid irreversible neurologic … drug take back centers
High-Dose Cytarabine in Acute Myeloid Leukemia Treatment: A …
Web1.Lowenberg B. Sense and nonsense of high dose cytarabine for acute myeloid leukemia. Blood 2013; 121: 26-28. Version 1 (April 2024) Page 4 of 5 AML–InP-Cytarabine (3000mg/m 2) REGIMEN SUMMARY InP-Cytarabine (3000mg/m 2) Other than those listed below, supportive medication for this regimen will ... Web16 dec. 2024 · Cytarabine doses are nowadays often divided into “standard” (100–200 mg/m 2 ), “intermediate” (400–1500 mg/m 2 ), and “high” (>2000 mg/m 2) [ 10 ]. The initial setting in which differing... WebHigh dose cytarabine (HDARAC) therapy is used increasingly to treat hematologic malignancies. Recent data indicate that HDARAC at doses of 2-3 g/M2 every 12 hr x 10-12 doses is of comparable or greater efficacy in remission induction as standard doses of cytarabine in acute myelogenous leukemia. HDA … drug take back box near me